Skip to content
10-Q

Quarterly Report

NUTEX HEALTH INC. NUTX

0001628280-25-053166

← back to feed
Filed
Nov 19, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 10, 2025 7.07M sh
Shares Diluted Q3 2025 · Sep 30, 2025 7.18M sh
Shares Diluted Q3 2025 · Sep 30, 2025 6.73M sh
Shares Diluted Q3 2025 · Sep 30, 2024 5.1M sh
Shares Diluted Q3 2025 · Sep 30, 2024 4.97M sh
Capex Q3 2025 · Sep 30, 2025 $1.12M
Capex Q3 2025 · Sep 30, 2024 $1.91M
Operating Cash Flow Q3 2025 · Sep 30, 2025 $177.74M
Operating Cash Flow restated Q3 2025 · Sep 30, 2024 $23.1M
Long Term Debt Q3 2025 · Sep 30, 2025 $25.57M
Long Term Debt Q3 2025 · Dec 31, 2024 $22.47M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $166.05M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $40.64M
Stockholders Equity Q3 2025 · Sep 30, 2025 $317.17M
Stockholders Equity Q3 2025 · Dec 31, 2024 $132.44M
Current Liabilities Q3 2025 · Sep 30, 2025 $185.46M
Current Liabilities Q3 2025 · Dec 31, 2024 $154.23M
Total Liabilities Q3 2025 · Sep 30, 2025 $526.49M
Total Liabilities Q3 2025 · Dec 31, 2024 $466.79M
Current Assets Q3 2025 · Sep 30, 2025 $592.65M
Current Assets Q3 2025 · Dec 31, 2024 $292.48M
Total Assets Q3 2025 · Sep 30, 2025 $964.52M
Total Assets Q3 2025 · Dec 31, 2024 $655.32M
Eps Diluted Q3 2025 · Sep 30, 2025 $7.76
Eps Diluted Q3 2025 · Sep 30, 2025 $8.87
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.72
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.91
Eps Basic Q3 2025 · Sep 30, 2025 $8.27
Eps Basic Q3 2025 · Sep 30, 2025 $9.63
Eps Basic Q3 2025 · Sep 30, 2024 −$1.72
Eps Basic Q3 2025 · Sep 30, 2024 −$1.91
Sga Expense Q3 2025 · Sep 30, 2025 $11.3M
Sga Expense Q3 2025 · Sep 30, 2025 $33.83M
Sga Expense restated Q3 2025 · Sep 30, 2024 $9.87M
Sga Expense restated Q3 2025 · Sep 30, 2024 $29.18M
Net Income Q3 2025 · Sep 30, 2025 $55.44M
Net Income Q3 2025 · Sep 30, 2025 $58.96M
Net Income restated Q3 2025 · Sep 30, 2024 −$8.79M
Net Income restated Q3 2025 · Sep 30, 2024 −$9.52M
Operating Income Q3 2025 · Sep 30, 2025 $130.37M
Operating Income Q3 2025 · Sep 30, 2025 $244.71M
Operating Income restated Q3 2025 · Sep 30, 2024 $9.66M
Operating Income restated Q3 2025 · Sep 30, 2024 $16.41M
Gross Profit Q3 2025 · Sep 30, 2025 $154.88M
Gross Profit Q3 2025 · Sep 30, 2025 $398.14M
Gross Profit restated Q3 2025 · Sep 30, 2024 $21.92M
Gross Profit restated Q3 2025 · Sep 30, 2024 $54.64M